Ascentage Pharma Group International
HKEX:6855
Ascentage Pharma Group International
HKEX:6855
Price:
46.6
HKD
1.39%
Market Closed
Market Cap:
HK$17.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Ascentage Pharma Group International
HKEX:6855
|
CN |
|
T
|
Trisul SA
BOVESPA:TRIS3
|
BR |
|
Penta Teknoloji Urunleri Dagitim Ticaret AS
IST:PENTA.E
|
TR |
|
MSR India Ltd
BSE:508922
|
IN |
|
Patanjali Foods Ltd
NSE:PATANJALI
|
IN |
|
GEPIC Energy Development Co Ltd
SZSE:000791
|
CN |
|
H
|
Holitech Technology Co Ltd
SZSE:002217
|
CN |
|
H
|
Hyflux Ltd
SGX:600
|
SG |
|
Grupo Famsa SAB de CV
BMV:GFAMSAA
|
MX |
Multiples-Based Value
The Multiples-Based Value of one
Ascentage Pharma Group International
stock under the Base Case scenario is
hidden
HKD.
Compared to the current market price of 46.6 HKD,
Ascentage Pharma Group International
is
hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Ascentage Pharma Group International Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
Ascentage Pharma Group International Competitors
Ascentage Pharma Group International Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
|
Ascentage Pharma Group International
HKEX:6855
|
17.4B HKD | 26.7 | -12.4 | -12.4 | -12.4 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
376.8B USD | 6.3 | 91.6 | 15.1 | 21 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
356.2B USD | 111.3 | -1 738.3 | 16 147.7 | -1 823.3 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.1B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.2B USD | 5.8 | 19.9 | 12.4 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.6B USD | 9.4 | 28.5 | 21.4 | 22.3 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.2B USD | 5.7 | 18.1 | 13.5 | 15.4 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.9B AUD | 3.1 | 34.8 | 11.5 | 14.4 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
